Edit Content

Contact Us


    Human Verification

    cropped-gtc_logo_grey_circle_2022

    Molecular Overlap Between Acute Myeloid Leukemia and Myelodysplastic Syndrome

    From Genomics to Cancer - May 2021

    Type:

    Webinar

    Date (start):

    May 18, 2021

    Date (end):

    May 18, 2021

    Location:

    HMH-NJ | GTC-CA

    Booth#:

    Admission Fee: 

    Overview:

    Presented by Dr. James McCloskey and Dr. Maher Albitar

    This Webinar will focus of the clinical relevance of distinguishing myelodysplastic syndrome from acute myeloid leukemia. It will discuss the diagnostic molecular abnormalities that define myelodysplastic syndrome (MDS)/Chronic myelomonocytic leukemia (CMML) and those that define acute myeloid leukemia (AML). Molecular changes associated with transformation from MDS to AML will also be discussed. Post therapy molecular abnormalities and the use of these abnormalities for monitoring and detecting minimal residual disease will also be presented and discussed.

    CME credits available